- Trusted Wholesaler in Global Healthcare
- [email protected]
- +6590395715
Drug name: Beleodaq (belinostat)
Drug alias: belinostat
English name: belinostat
R&D company: Spectrum Pharms
Indications: Peripheral T-cell lymphoma
Model specification: 500mg
Beleodaq is used to treat patients with relapsed or refractory peripheral T-cell lymphoma.
Beleodaq is an injection, 500 mg per unit, and the recommended dose is 1000 mg once a day by intravenous injection.
Beleodaq should be discontinued in the event of disease progression or toxic side effects.
CareMed Pharmaceutical Limited is a leading provider of trading services for the importation, marketing, and distribution of healthcare products nationwide.
© 2024 CareMed Pharmaceutical Limited · Developed By Channel Soft Solution
English 
Chinese